Sign in
CompletedPhase 4

Intranasal Dexmedetomidine Versus Oral Midazolam Premedication for Postoperative Negative Behavior Changes in Children

Key facts

Who runs it
Fujian Provincial Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
324 people enrolled
Started
22 May 2024
Ended
21 Oct 2025
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Dexmedetomidine Hydrochloride
  • Midazolam
  • normal Saline
  • Glucose solution
Record updated
30 July 2026

Who can take part

Age
2 years to 5 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • ASA physical status I or II
  • Aged 2-5 years
  • Scheduled for elective tonsillectomy and (or) adenoidectomy

Who cannot take part

  • Intake of sedative or analgesic medication within 48 hours before surgery
  • Major life changes 1 month before the operation, such as the divorce of parents, death of parents, moving to a new home, changing to a new kindergarten, etc
  • Allergy to study drugs
  • Any other conditions that precluded study inclusion
  • Parents refusing to allow their children to participate
  • Developmental delay
  • Psychosis
  • Body mass index > 30 kg/m2

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn the effect of dexmedetomidine premedication in postoperative negative behavior changes in children compared to midazolam premedication. It will also learn about the effect of dexmedetomidine and midazolam in emergence delirium. The main questions are:

Read full original descriptionShow less

* Dose dexmedetomidine lower the incidence of postoperative negative behavior changes compared to midazolam? * Dose dexmedetomidine lower the incidence of emergence delirium compared to midazolam? Researchers will compare dexmedetomidine to midazolam (a common pediatric premedication) to see if dexmedetomidine works to treat postoperative negative behavior change and emergence delirium.

Participants will:

* Take intranasal dexmedetomidine or oral midazolam or placebo (a look-alike substance that contains no drug) premedication * Fill in the Post hospitalization behavior questionnaire for ambulatory surgery postoperative 1, 3, 7, and 30

The 3 groups in the trial

  • Dexmedetomidine groupTreatment being tested

    Participants were premedicated with intranasal dexmedetomidine 2 μg/kg and oral sweet solution 0.25 mL/kg.

    Treatment: Dexmedetomidine Hydrochloride and Glucose solution

  • Midazolam groupExisting treatment, for comparison

    Participants were premedicated with intranasal 0.9% saline 0.02 mL/kg and oral midazolam 0.5 mg/kg.

    Treatment: Midazolam and normal Saline

  • Placebo groupPlacebo, for comparison

    Participants were premedicated with intranasal 0.9% saline 0.02 mL/kg and oral sweet solution 0.25 mL/kg.

    Treatment: normal Saline and Glucose solution

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Intranasal Dexmedetomidine Versus Oral Midazolam Premedication for Postoperative Negative Behavior Changes in Children: A Randomized Controlled Trial
Record updated
30 July 2026